Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV000003690 | SCV001752548 | likely pathogenic | Dalmatian hypouricemia | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001851625 | SCV002259167 | likely pathogenic | not provided | 2024-10-31 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 217 of the SLC22A12 protein (p.Thr217Met). This variant is present in population databases (rs121907893, gnomAD 0.05%). This missense change has been observed in individual(s) with clinical features of hypouricemia (PMID: 12024214, 14694169, 23043931, 31591475). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 3513). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SLC22A12 function (PMID: 12024214). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
OMIM | RCV000003690 | SCV000023853 | pathogenic | Dalmatian hypouricemia | 2002-05-23 | no assertion criteria provided | literature only |